Published in Expert Rev Neurother on October 01, 2012
Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry (2005) 7.90
Initial impact of the Fast Track prevention trial for conduct problems: I. The high-risk sample. Conduct Problems Prevention Research Group. J Consult Clin Psychol (1999) 6.63
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2007) 6.57
Initial impact of the Fast Track prevention trial for conduct problems: II. Classroom effects. Conduct Problems Prevention Research Group. J Consult Clin Psychol (1999) 5.21
Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA (2009) 3.69
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol (2008) 3.63
Genetic and environmental influences on behavioral disinhibition. Am J Med Genet (2000) 3.61
Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry (2005) 3.51
Conduct disorder and oppositional defiant disorder in a national sample: developmental epidemiology. J Child Psychol Psychiatry (2004) 3.34
Research review: DSM-V conduct disorder: research needs for an evidence base. J Child Psychol Psychiatry (2008) 2.48
Testing an idealized dynamic cascade model of the development of serious violence in adolescence. Child Dev (2008) 2.41
Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry (2002) 2.37
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics (2008) 2.22
Fast track randomized controlled trial to prevent externalizing psychiatric disorders: findings from grades 3 to 9. J Am Acad Child Adolesc Psychiatry (2007) 2.12
Behavioral disinhibition: liability for externalizing spectrum disorders and its genetic and environmental relation to response inhibition across adolescence. J Abnorm Psychol (2009) 2.08
Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry (2002) 2.01
Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry (2002) 1.89
Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics (2002) 1.87
Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol (2000) 1.81
A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev (2008) 1.78
Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry (2009) 1.73
A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type. J Am Acad Child Adolesc Psychiatry (2007) 1.73
Evaluation of a high school peer group intervention for at-risk youth. J Abnorm Child Psychol (2005) 1.69
Sources of covariation among attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder: the importance of shared environment. J Abnorm Psychol (2001) 1.67
Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems. J Am Acad Child Adolesc Psychiatry (2005) 1.61
Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res (2010) 1.56
The effects of the fast track preventive intervention on the development of conduct disorder across childhood. Child Dev (2011) 1.50
Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol (2005) 1.47
Symptoms of conduct disorder, oppositional defiant disorder, attention-deficit/hyperactivity disorder, and callous-unemotional traits as unique predictors of psychosocial maladjustment in boys: advancing an evidence base for DSM-V. J Am Acad Child Adolesc Psychiatry (2010) 1.42
Development and etiology of disruptive and delinquent behavior. Annu Rev Clin Psychol (2009) 1.39
Genetic basis of attention deficit and hyperactivity. Br J Psychiatry (1999) 1.38
Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol (2001) 1.37
Combining parent and child training for young children with ADHD. J Clin Child Adolesc Psychol (2011) 1.36
Social skills training with parent generalization: treatment effects for children with attention deficit disorder. J Consult Clin Psychol (1997) 1.33
Perspectives on oppositional defiant disorder, conduct disorder, and psychopathic features. J Child Psychol Psychiatry (2009) 1.32
Attention-deficit/hyperactivity disorder and social dysfunctioning. Clin Psychol Rev (2007) 1.31
A developmental framework for distinguishing disruptive behavior from normative misbehavior in preschool children. J Child Psychol Psychiatry (2007) 1.31
Attention deficit disorder with hyperactivity: a specific hypothesis of reward dysfunction. J Am Acad Child Adolesc Psychiatry (1987) 1.28
The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med (2008) 1.26
A common genetic factor explains the covariation among ADHD ODD and CD symptoms in 9-10 year old boys and girls. J Abnorm Child Psychol (2009) 1.25
Proximal peer-level effects of a small-group selected prevention on aggression in elementary school children: an investigation of the peer contagion hypothesis. J Abnorm Child Psychol (2005) 1.25
Development of a school-based treatment program for middle school youth with ADHD. J Atten Disord (2005) 1.24
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol (2007) 1.21
Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. J Child Adolesc Psychopharmacol (2003) 1.21
Genetic and environmental causes of covariation in interview assessments of disruptive behavior in child and adolescent twins. Behav Genet (2000) 1.20
Impulsive and callous traits are more strongly associated with delinquent behavior in higher risk neighborhoods among boys and girls. J Abnorm Psychol (2008) 1.19
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord (2008) 1.18
Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2009) 1.16
Classification of behavior disorders in adolescence: scaling methods, predictive validity, and gender differences. J Abnorm Psychol (2010) 1.15
Co-occurring problems of early onset persistent, childhood limited, and adolescent onset conduct problem youth. J Child Psychol Psychiatry (2010) 1.13
Parent-assisted transfer of children's social skills training: effects on children with and without attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1997) 1.12
Effectiveness of the Challenging Horizons After-School Program for young adolescents with ADHD. Behav Ther (2011) 1.11
The effects of self-management in general education classrooms on the organizational skills of adolescents with ADHD. Behav Modif (2006) 1.10
Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry (2005) 1.09
Parental influence on children with attention-deficit/hyperactivity disorder: II. Results of a pilot intervention training parents as friendship coaches for children. J Abnorm Child Psychol (2010) 1.07
Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr (2008) 1.07
Materials Organization, Planning, and Homework Completion in Middle School Students with ADHD: Impact on Academic Performance. School Ment Health (2011) 1.04
Bidirectional links and concurrent development of parent-child relationships and boys' offending behavior. J Abnorm Psychol (2011) 1.04
Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 1.02
Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. J Child Neurol (2008) 1.01
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol (2010) 1.00
The importance of friendship for youth with attention-deficit/hyperactivity disorder. Clin Child Fam Psychol Rev (2010) 1.00
Peer problems in Attention Deficit Hyperactivity Disorder: current status and future directions. Dev Disabil Res Rev (2008) 0.99
Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study. J Am Acad Child Adolesc Psychiatry (2007) 0.97
Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology (Berl) (2006) 0.97
Attention-deficit/hyperactivity disorder and oppositional/conduct problems: links to parent-child interactions. J Can Acad Child Adolesc Psychiatry (2007) 0.96
Genotype and neuropsychological response inhibition as resilience promoters for attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder under conditions of psychosocial adversity. Dev Psychopathol (2007) 0.93
Consultation-based academic interventions for children with ADHD: effects on reading and mathematics achievement. J Abnorm Child Psychol (2006) 0.88
Deviant peer affiliation and antisocial behavior: interaction with Monoamine Oxidase A (MAOA) genotype. J Abnorm Child Psychol (2011) 0.86
How do children with ADHD (mis)manage their real-life dyadic friendships? A multi-method investigation. J Abnorm Child Psychol (2011) 0.86
Interventions to enhance social competence. Child Adolesc Psychiatr Clin N Am (2000) 0.85
Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2005) 0.81
Effects of reinforcement on concept identification in hyperactive children. J Abnorm Child Psychol (1983) 0.80
Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol (2012) 2.86
The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K). Yonsei Med J (2004) 2.26
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics (2008) 2.22
A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type. J Am Acad Child Adolesc Psychiatry (2007) 1.73
Waxing and waning in concert: dynamic comorbidity of conduct disorder with other disruptive and emotional problems over 7 years among clinic-referred boys. J Abnorm Psychol (2002) 1.52
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med (2006) 1.26
Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol (2005) 1.22
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial. J Child Adolesc Psychopharmacol (2013) 1.19
ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry (2003) 1.09
ADHD subtype differences in motivational responsivity but not inhibitory control: evidence from a reward-based variation of the stop signal paradigm. J Clin Child Adolesc Psychol (2007) 1.08
A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr (2010) 1.07
Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr (2008) 1.07
Validity of the sluggish cognitive tempo, inattention, and hyperactivity symptom dimensions: neuropsychological and psychosocial correlates. J Abnorm Child Psychol (2012) 0.97
Can executive functions explain the relationship between Attention Deficit Hyperactivity Disorder and social adjustment? J Abnorm Child Psychol (2009) 0.97
Validity of the sluggish cognitive tempo symptom dimension in children: sluggish cognitive tempo and ADHD-inattention as distinct symptom dimensions. J Abnorm Child Psychol (2014) 0.96
Social skills differences among attention-deficit/hyperactivity disorder types in a chat room assessment task. J Abnorm Child Psychol (2007) 0.95
Structure and validity of sluggish cognitive tempo using an expanded item pool in children with attention-deficit/hyperactivity disorder. J Abnorm Child Psychol (2014) 0.95
ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry (2005) 0.92
Sluggish cognitive tempo in abnormal child psychology: an historical overview and introduction to the special section. J Abnorm Child Psychol (2014) 0.92
Educational outcomes of a collaborative school-home behavioral intervention for ADHD. Sch Psychol Q (2013) 0.89
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2006) 0.88
Sibling relationships among children with ADHD. J Atten Disord (2007) 0.87
Child ADHD severity and positive and negative parenting as predictors of child social functioning: evaluation of three theoretical models. J Atten Disord (2010) 0.87
Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol (2006) 0.82
Additive effects of parent adherence on social and behavioral outcomes of a collaborative school-home behavioral intervention for ADHD. Child Psychiatry Hum Dev (2014) 0.80
Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol (2007) 0.80
Bifactor latent structure of ADHD/ODD symptoms: predictions of dual-pathway/trait-impulsivity etiological models of ADHD. J Child Psychol Psychiatry (2014) 0.79
Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents. Clin Ther (2013) 0.78
Negative social preference in relation to internalizing symptoms among children with ADHD predominantly inattentive type: girls fare worse than boys. J Clin Child Adolesc Psychol (2013) 0.77
Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2014) 0.77
New directions for therapeutics in ADHD. Neurotherapeutics (2012) 0.75
Treatment of aggressive ADHD in children and adolescents: conceptualization and treatment of comorbid behavior disorders. Postgrad Med (2009) 0.75
Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13 Month Follow-up. J Am Acad Child Adolesc Psychiatry (2020) 0.75